NYSE - Delayed Quote • USD
STERIS plc (STE)
At close: April 23 at 4:00 PM EDT
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
934,266.00
756,947.00
684,811.00
689,640.00
Investing Cash Flow
-869,332.00
-383,330.00
-666,559.00
-1,154,159.00
Financing Cash Flow
-133,364.00
-498,718.00
115,830.00
345,620.00
End Cash Position
190,941.00
208,357.00
348,320.00
220,531.00
Capital Expenditure
-340,278.00
-361,969.00
-287,563.00
-239,262.00
Issuance of Debt
48,940.00
--
2,000,000.00
550,000.00
Repayment of Debt
-60,000.00
-247,875.00
-1,437,645.00
-35,000.00
Repurchase of Capital Stock
-166,053.00
-308,565.00
-55,777.00
-14,646.00
Free Cash Flow
593,988.00
394,978.00
397,248.00
450,378.00
3/31/2021 - 6/1/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNN Smith & Nephew plc
24.80
+1.81%
CNMD CONMED Corporation
71.31
-1.79%
TMCI Treace Medical Concepts, Inc.
10.86
-2.16%
ZBH Zimmer Biomet Holdings, Inc.
121.52
+0.61%
PODD Insulet Corporation
167.27
+1.73%
SYK Stryker Corporation
334.91
+2.21%
TELA TELA Bio, Inc.
4.4700
-2.19%
BSX Boston Scientific Corporation
68.99
+1.43%
RPID Rapid Micro Biosystems, Inc.
0.9289
+6.65%
PEN Penumbra, Inc.
205.70
+1.33%